4.7 Article

The risky business of drug development in neurology

Journal

LANCET NEUROLOGY
Volume 10, Issue 2, Pages 116-117

Publisher

Elsevier BV
DOI: 10.1016/s1474-4422(11)70004-7

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available